Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Wagner

Showing results (111-120 of 303) with videos related to

Pageof 31
Sort By:
Journal of Pediatric Hematology/Oncology|April 1, 2008
Clot strength: a comparison between cord and adult blood by means of thrombelastometryGerhard Cvirn, Siegfried Gallistl, Joerg Kutschera, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 2007
Collagen/endogenous thrombin-induced platelet aggregation in whole blood samplesGerhard Cvirn, Siegfried Gallistl, Joerg Kutschera, et al.
Clinical Laboratory|December 15, 2010
Heparinase-modified thrombelastometry: inactivation of heparin in plasma samplesGerhard Cvirn, Erwin Tafeit, Gerd Hoerl, et al.
Clinical and Translational Science|May 22, 2023
Population pharmacokinetics, enzyme occupancy, and 24S-hydroxycholesterol modeling of soticlestat, a novel cholesterol 24-hydroxylase inhibitor, in healthy adultsWei Yin, Axel Facius, Thomas Wagner, et al.
Circulation Research|August 12, 2006
An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophyPeiyong Zhai, Jonathan Galeotti, Jing Liu, et al.
Transfusion|October 27, 2015
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasisSusanne Macher, Thomas Wagner, Konrad Rosskopf, et al.
Biochemical Pharmacology|April 19, 2002
Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activitySvenja K Brueggemann, Peter Schlenke, Stephanie Klich, et al.
Transfusion|July 24, 2019
RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expressionEva Maria Matzhold, Helene Polin, Günther F Körmöczi, et al.
EJNMMI Research|January 17, 2017
Patient-specific optimisation of administered activity and acquisition times for <sup>18</sup>F-FDG PET imagingFred Wickham, Helena McMeekin, Maria Burniston, et al.
European Radiology|April 30, 2026
PSMA PET: the answer to MRI-occult prostate cancer… or another mirage?Thomas Wagner, Mark Emberton, Iztok Caglic, et al.
Pageof 31

Showing results (111-120 of 303) with videos related to

Sort By:
Pageof 31
Journal of Pediatric Hematology/Oncology|April 1, 2008
Clot strength: a comparison between cord and adult blood by means of thrombelastometryGerhard Cvirn, Siegfried Gallistl, Joerg Kutschera, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|September 1, 2007
Collagen/endogenous thrombin-induced platelet aggregation in whole blood samplesGerhard Cvirn, Siegfried Gallistl, Joerg Kutschera, et al.
Clinical Laboratory|December 15, 2010
Heparinase-modified thrombelastometry: inactivation of heparin in plasma samplesGerhard Cvirn, Erwin Tafeit, Gerd Hoerl, et al.
Clinical and Translational Science|May 22, 2023
Population pharmacokinetics, enzyme occupancy, and 24S-hydroxycholesterol modeling of soticlestat, a novel cholesterol 24-hydroxylase inhibitor, in healthy adultsWei Yin, Axel Facius, Thomas Wagner, et al.
Circulation Research|August 12, 2006
An angiotensin II type 1 receptor mutant lacking epidermal growth factor receptor transactivation does not induce angiotensin II-mediated cardiac hypertrophyPeiyong Zhai, Jonathan Galeotti, Jing Liu, et al.
Transfusion|October 27, 2015
Severe case of fetal hemolytic disease caused by anti-C(w) requiring serial intrauterine transfusions complicated by pancytopenia and cholestasisSusanne Macher, Thomas Wagner, Konrad Rosskopf, et al.
Biochemical Pharmacology|April 19, 2002
Stem cell toxicity of oxazaphosphorine metabolites in comparison to their antileukemic activitySvenja K Brueggemann, Peter Schlenke, Stephanie Klich, et al.
Transfusion|July 24, 2019
RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expressionEva Maria Matzhold, Helene Polin, Günther F Körmöczi, et al.
EJNMMI Research|January 17, 2017
Patient-specific optimisation of administered activity and acquisition times for <sup>18</sup>F-FDG PET imagingFred Wickham, Helena McMeekin, Maria Burniston, et al.
European Radiology|April 30, 2026
PSMA PET: the answer to MRI-occult prostate cancer… or another mirage?Thomas Wagner, Mark Emberton, Iztok Caglic, et al.
Pageof 31